Introduction
Theranostics is one of the most advanced developments in modern cancer care, combining molecular imaging and targeted therapy to diagnose, visualize, and treat cancer cells using the same radioactive tracer.
Türkiye is rapidly becoming a global leader in theranostic oncology due to its advanced nuclear medicine departments, cutting-edge imaging technologies, and experienced multidisciplinary specialists.
Averia Health ensures a seamless, safe, and fully coordinated theranostic journey for international patients — from evaluation and imaging to therapy and long-term monitoring.
Why Choose Türkiye for Theranostic Cancer Applications
Türkiye offers world-class theranostic treatment because:
- Internationally accredited nuclear medicine centers
- Advanced PET-CT and SPECT technology for precise tumor targeting
- Experienced nuclear medicine specialists and oncologists
- Availability of modern theranostic agents such as Lu-177 PSMA and Lu-177 DOTATATE
- High safety standards and controlled radiation protocols
- Fast scheduling and efficient evaluation systems
- More accessible treatment compared to Europe and the US
- Integrated care between oncology, radiology, and nuclear medicine teams
Türkiye delivers high-level precision oncology with proven results.
Why Choose Averia Health
Averia Health provides a well-coordinated, ethical, and supportive theranostic experience:
- Personalized evaluation based on your cancer type, imaging, and previous treatments
- Access to top nuclear medicine and oncology departments
- Fast coordination of PET-CT and suitability assessments
- Clear communication and evidence-based guidance
- Support with travel, accommodation, and hospital logistics
- 24/7 assistance throughout your stay
- Long-term follow-up for monitoring treatment response
We prioritize safety, accuracy, and compassionate patient support.
Available Theranostic Treatments & Techniques
Lutetium-177 PSMA Therapy (Lu-177 PSMA)
A targeted radioligand therapy for advanced prostate cancer, binding specifically to PSMA-positive cancer cells.
- Accurate targeting
- Reduced side effects compared to systemic therapies
- Improved quality of life
- Often used after chemotherapy or hormone therapies
Lutetium-177 DOTATATE Therapy (Lu-177 DOTATATE)
A molecular therapy for neuroendocrine tumors (NETs) expressing somatostatin receptors.
- High tumor uptake
- Effective symptom control
- Proven survival benefits
Actinium-225 PSMA Therapy (Ac-225 PSMA)
An advanced targeted radionuclide treatment used for selected patients with advanced prostate cancer.
Actinium-225 DOTATATE Therapy (Ac-225 DOTATATE)
an advanced form of alpha-particle peptide receptor radionuclide therapy (PRRT) used for selected patients with neuroendocrine tumors (NETs).
Theranostic PET Imaging
Used to determine therapy eligibility and assess tumor uptake:
- Ga-68 PSMA PET-CT for prostate cancer
- Ga-68 DOTATATE PET-CT for neuroendocrine tumors
- Other tracer-based PET imaging for emerging theranostic applications
Radioiodine Therapy (I-131)
A targeted treatment for:
- Thyroid cancer
- Hyperthyroidism
- Residual thyroid tissue following surgery
MIBG Therapy (¹³¹I-MIBG)
a targeted nuclear medicine treatment used for selected neuroendocrine tumors that actively uptake metaiodobenzylguanidine (MIBG).
Bone Pain Palliation Therapy
For metastatic cancer affecting the bones using radiopharmaceuticals that target bone lesions.
Y-90 Therapy (Radioembolization)
Is a targeted internal radiation treatment used primarily for liver tumors, including both primary liver cancer and liver metastases.
Emerging Theranostic Applications
Depending on center capabilities, may include:
- Alpha-emitter therapies
- Novel radioligand treatments
- Research-based molecular therapies
(All offered strictly according to medical and regulatory standards.)
Treatment Journey in Türkiye
- Pre-Arrival Consultation
You submit PET-CT results, pathology reports, and oncologist notes for evaluation. - Specialist Review
Nuclear medicine physicians assess your eligibility for theranostic therapy. - Travel Planning & Scheduling
Averia Health coordinates all appointments, imaging, and hospitalization needs. - Arrival in Türkiye
Airport pickup and transfer to your accommodation. - PET-CT Imaging & Clinical Evaluation
Confirm receptor positivity (PSMA or DOTATATE) and suitability for treatment. - Theranostic Treatment
Radioisotope therapy administered in a controlled nuclear medicine environment. - Monitoring & Care
Vital signs, kidney function, and radiation safety protocols are monitored closely. - Post-Return Follow-Up
We assist with long-term evaluation, imaging intervals, and therapy response tracking.
Expected Results & Recovery
- Improved symptom control and quality of life
- Potential reduction in tumor size or metabolic activity
- Mild fatigue, dry mouth, or nausea may occur temporarily
- Rare side effects include mild blood count suppression
- Most patients resume normal routines shortly after treatment
- Follow-up PET scans help track treatment response
Your oncology and nuclear medicine teams will provide precise aftercare instructions.
Risks & Considerations
Theranostic treatments are generally safe but involve important considerations:
- Radiation exposure (carefully controlled)
- Temporary changes in kidney or salivary gland function
- Rare blood cell count suppression
- Not suitable for all patients — requires PET confirmation and organ function screening
Türkiye follows strict international safety and radiation guidelines for all theranostic procedures.
Your nuclear medicine specialist will thoroughly explain suitability and risks.
What’s Included in Your Medical Trip
- Airport pickup & drop-off
- Hotel accommodation support
- All hospital and imaging transfers
- Translator/interpreter services
- Full coordination of PET-CT, therapy sessions, and specialist consultations
- Priority access to top oncologists and nuclear medicine teams
- 24/7 assistance during your stay
- Post-treatment follow-up and support
Averia Health ensures an organized, safe, and fully supported theranostic journey.
Frequently Asked Questions
What cancers can be treated with theranostics?
Currently prostate cancer (PSMA) and neuroendocrine tumors (DOTATATE) are the main indications.
How is eligibility determined?
Through PET-CT scans using PSMA or DOTATATE, plus blood tests and organ function evaluations.
Is theranostic therapy safe?
Yes — it uses targeted radiation with fewer side effects than many systemic treatments.
How soon do results appear?
Many patients observe improvements within weeks to months, depending on tumor biology.
Can I fly after treatment?
Yes — after a short monitoring period your specialist will confirm suitability for travel.
Is multiple therapy cycles required?
Most patients receive 2–6 cycles depending on response and medical assessment.
Ready to Start Your Health Journey?
Advanced, targeted cancer care begins with expert precision.
Request a free quote or contact us on WhatsApp to begin your theranostic evaluation in Türkiye.
